Deals: Page 86
-
Abbott selling part of generics portfolio to Mylan
The transaction, which is valued at $5.3 billion, will close in Q1 2015
By Nicole Gray • July 15, 2014 -
HD Biosciences, Marshall U. launch Chinese drug venture
The partners will share costs, risks of development.
By Nicole Gray • July 14, 2014 -
Bayer, Oxford partner on gynecology research
Endometriosis and uterine fibroids affect millions of women worldwide.
By Nicole Gray • July 14, 2014 -
Pfizer, CliniWorks creating health management platform
It is being developed to deliver real-time healthcare that is both more efficient and more effective.
By Nicole Gray • July 11, 2014 -
Allergan making moves to be leaner
As Valeant’s hostile takeover efforts continue, Allergan starts cutting costs.
By Nicole Gray • July 10, 2014 -
Newly acquired Forest Labs lays off 190 employees in Missouri
With the Actavis takeover complete, changes are underway.
By Nicole Gray • July 10, 2014 -
AbbVie makes fresh bid for Shire
Richard Gonzalez, AbbVie's CEO, notes numerous synergies and sweetens the deal.
By Nicole Gray • July 9, 2014 -
AstraZeneca teaming up with Max Planck Institute to advance R&D
The focus will be on metabolic and cardiovascular diseases.
By Nicole Gray • July 9, 2014 -
Lilly, Yabao develop, market diabetes drug
The combined capabilities will give the two a presence in China and global reach.
By Nicole Gray • July 8, 2014 -
Hedge fund nominates Allergan slate as takeover fight escalates
The Botox manufacturer scoffs at claims the nominees are independent of the two suitors.
By Nicole Gray • July 8, 2014 -
Deep Dive
Valeant may have antidote for Allergan's 'poison pill'
Ultimately, the issue might be resolved by a boardroom fight.
By Nicole Gray • July 7, 2014 -
Jazz Pharmaceuticals acquires North, South American rights to defibrotide
The company continues to bolster its clinical and commercial expertise in the fields.
By Nicole Gray • July 3, 2014 -
ANI plans immediate launch of Lithobid
The company is expecting immediate sales revenues approaching $4 million as it builds a mature brands portfolio.
By Nicole Gray • July 3, 2014 -
Quintiles acquires Encore Health Services
The acquisition underscores the value of informatics expertise.
By Nicole Gray • July 3, 2014 -
Carlyle Group buys diagnostics business from J&J
With the acquisition, the private equity investment firm becomes a bigger player in the biopharma space.
By Nicole Gray • July 3, 2014 -
Transcept and Paratek Pharma to merge
Investors infuse more capital to support development of the company’s lead antibiotic candidate.
By Nicole Gray • July 2, 2014 -
Cidara Therapeutics completes $32 million financing for immunotherapy research
The company wants to change the standard of care for invasive fungal infections.
By Nicole Gray • July 1, 2014 -
CHMP recommends Eliquis for recurrent thrombotic events
Positive response was based on clinical data on almost 8,000 patients who had experienced a previous thrombotic event.
By Nicole Gray • June 30, 2014 -
Roche making $5 million milestone payment to Halozyme
The payment for the two companies' MabThera SC collaboration comes as the drug is launched in Europe.
By Nicole Gray • June 30, 2014 -
Shire prevails in patent suit, gains traction against AbbVie takeover bid
The ruling could help Shire in its ongoing battle.
By Nicole Gray • June 26, 2014 -
Valeant pursuing shareholder support in Allergan bid
Its takeover effort turns more aggressive.
By Nicole Gray • June 26, 2014 -
Melanoma drug trial stopped early after positive results
The decision could cheer Bristol-Myers Squibb stockholders -- and the medical community.
By Nicole Gray • June 25, 2014 -
Bayer, Dimension Therapeutics collaborating on hemophilia A gene therapy
If the treatment makes it to market, it will be a major game-changer for patients.
By Nicole Gray • June 25, 2014 -
Inovio initiates early-stage clinical trials for cervical cancer drug
The candidate is part of the emerging class of immuno-oncologic drugs.
By Nicole Gray • June 25, 2014 -
Sanofi, Merrimack continue development of molecular target found in many cancers
An extensive phase II clinical trial program is underway.
By Nicole Gray • June 22, 2014
Previous
